Supportive evidence that low FGF-21 concentrations are deleterious for patients suffering from Candida infections comes from a study showing an upregulation of FGF-21 concentrations in patients with chronic mucocutaneous candidiasis after successful treatment with a JAK inhibitor [23]. This evidence concerns the gene FGF21 and chronic mucocutaneous candidiasis.